Evidence map›Paper›PMID 38438213›Full record

ArticleSaudi medical journal2024

Outcomes of etonogestrel subdermal contraceptive implants: A single center cross-sectional study.

Taghreed M Shams, Hashem H Alhashemi, Albaraa A Fallatah, Asma M Alkhalid, Fai M Alhazmi, Mohammed K Bin Yunus, Rani N Radey, Asalah F Hamad, Hatoon T Beyari, Shahad S Alharazi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Taghreed M ShamsFrom the Department of Obstetrics and Gynecology (Shams), College of Medicine, King Saud bin Abdulaziz University For Health Sciences.ORCID https://orcid.org/0000-0002-0454-406X
Hashem H Alhashemifrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Albaraa A Fallatahfrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Asma M Alkhalidfrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Fai M Alhazmifrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Mohammed K Bin Yunusfrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Rani N Radeyfrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Asalah F Hamadfrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Hatoon T Beyarifrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Shahad S Alharazifrom the Department of Obstetrics and Gynecology (Shams, Hamad, Beyari, Alharazi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Medicine(Alhashemi), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Batterjee Medical College (Alkhalid, Alhazmi), Jeddah, from King Abdullah International Medical Research Center, Riyadh; from the College of Medicine (Fallatah, Bin Yunus), Taibah University, Al-Madinah Al-Munawwarah, and from the College of Medicine (Radey), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Umm al-Qura University · SAKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the prevalence of menstrual irregularities, side effects, and discontinuation rates of etonogestrel subdermal implants (ESI) in women attending King Abdulaziz Medical City, Jeddah, Saudi Arabia.

methodsThis cross-sectional was carried out based on electronic medical records and a phone-based questionnaire administered to women who underwent ESI insertion in a single tertiary care hospital in Jeddah, Saudi Arabia, between 2019 and 2022. The primary objective was the prevalence of menstrual abnormalities. The secondary study objective included the discontinuation rate, reasons for discontinuation, and ESI side effects.

resultsIn total, 345 women with ESI were included in this study. The prevalence of any type of menstrual abnormalities was 88%. Other side effects included skin and mood changes, arm pain, and numbness. The discontinuation rate was 11% in the first year and 22% before the completion of 36 months.

conclusionAlthough menstrual abnormalities are a common side effect of ESI, only 22% of users discontinued this method of contraception.

Indexed as

DesogestrelElectronic Health RecordsContraceptive AgentsCross-Sectional StudiesFemaleHumansContraceptive AgentsDesogestreletonogestrelcontraceptionetonogestrelimplantsmenstrual abnormalities

Identifiers

PMID38438213
PMCPMC11115393
OpenAlexW4392381492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.